Shuko Nojiri

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies

Ayami Okuzumi, Taku Hatano, Gen Matsumoto et al. · Nature Medicine · 2023 · 321 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease

Shinji Saiki, Taku Hatano, Motoki Fujimaki et al. · Scientific Reports · 2017 · 143 citations · Full text

Life Sciences, Biochemistry, Metabolic Stability +14

A metabolic profile of polyamines in parkinson disease: A promising biomarker

Shinji Saiki, Yukiko Sasazawa, Motoki Fujimaki et al. · Annals of Neurology · 2019 · 123 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Sarcopenic obesity is associated with cognitive impairment in community-dwelling older adults: The Bunkyo Health Study

Yuki Someya, Yoshifumi Tamura, Hideyoshi Kaga et al. · Clinical Nutrition · 2022 · 93 citations

Medicine, Geriatric Medicine, Nutrition +15

Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease

Akie Midorikawa‐Inomata, Takenori Inomata, Shuko Nojiri et al. · BMJ Open · 2019 · 92 citations · Full text

Health Professions, Dermatology, Ophthalmology +15